Lataa...
Targeting Functional Biomarkers in Schizophrenia with Neuroimaging
Many of the most debilitating symptoms for psychiatric disorders such as schizophrenia remain poorly treated. As such, the development of novel treatments is urgently needed. Unfortunately, the costs associated with high failure rates for investigational compounds as they enter clinical trials has l...
Tallennettuna:
| Julkaisussa: | Curr Pharm Des |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4854787/ https://ncbi.nlm.nih.gov/pubmed/26818860 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|